Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 172

Results For "products"

2014 News Found

Roche retains its sustainability ranking in the Dow Jones Sustainability Indices
Sustainability | November 15, 2021

Roche retains its sustainability ranking in the Dow Jones Sustainability Indices

The company performed particularly well in operational eco-efficiency, environmental and social reporting


European Commission approves Ronapreve to treat Covid-19
Drug Approval | November 13, 2021

European Commission approves Ronapreve to treat Covid-19

Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus


Thermo Fisher to set up manufacturing facility in Mebane N.C.
Medical Device | November 13, 2021

Thermo Fisher to set up manufacturing facility in Mebane N.C.

The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics


Natco Pharma PAT at Rs 65.1 cr. in Q2FY22
News | November 12, 2021

Natco Pharma PAT at Rs 65.1 cr. in Q2FY22

Natco Pharma has reported consolidated financial results for the period ended September 30, 2021


Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
Biotech | November 12, 2021

Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients

A final decision regarding the approval of Ronapreve is expected from the European Commission shortly


Sun Pharma to introduce molnupiravir in India
Drug Approval | November 12, 2021

Sun Pharma to introduce molnupiravir in India

The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India


Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
News | November 12, 2021

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22

Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.


Hester Biosciences to acquire 50 % stake in Thrishool Exim, Tanzania
News | November 11, 2021

Hester Biosciences to acquire 50 % stake in Thrishool Exim, Tanzania

The consideration for the acquisition is US $ 2.25 million


Sudeep Pharma ventures into nutrition
Healthcare | November 11, 2021

Sudeep Pharma ventures into nutrition

Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers


India Pharmaceutical Market grows 5% in October 2021
News | November 10, 2021

India Pharmaceutical Market grows 5% in October 2021

Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22